Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000342321

Medchemexpress LLC GSK3368715 (EPZ019997) | 1629013-22-4 | 99.4% | 50 MG
SDP

Catalog No. 5000342321
Encompass_Preferred

GSK3368715 (EPZ019997) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor. It shifts arginine methylation states, alters exon usage, and possesses strong anti-cancer activity.

  • Orally active and reversible PRMT inhibitor
  • Inhibits PRMT1 (IC50 3.1 nM), PRMT3 (IC50 48 nM), PRMT6 (IC50 5.7 nM), and PRMT8 (IC50 1.7 nM)
  • Shows 50% or more growth inhibition in the majority of 249 cancer cell lines
  • Significantly affects growth of BxPC3 xenografts, reducing tumor growth by up to 97%

Catalog No. 50-003-42321 Supplier Medchemexpress LLC Supplier No. HY12871750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK3368715 (EPZ019997) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor. It shifts arginine methylation states, alters exon usage, and possesses strong anti-cancer activity.

  • Orally active and reversible PRMT inhibitor
  • Inhibits PRMT1 (IC50 3.1 nM), PRMT3 (IC50 48 nM), PRMT6 (IC50 5.7 nM), and PRMT8 (IC50 1.7 nM)
  • Shows 50% or more growth inhibition in the majority of 249 cancer cell lines
  • Significantly affects growth of BxPC3 xenografts, reducing tumor growth by up to 97%

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.